Oct 11, 2020 by Jason Hawthorne3 Stocks to Buy No Matter What Happens in NovemberForget politics and a pandemic. The outlook for these stocks keeps getting better, and analysts can't keep up.
Oct 10, 2020 by Jason HawthorneForget Snowflake! Buy This Ultra-High-Growth StockAfter doubling sales last year, this vaccine maker is speeding toward a revolution in the way humans prevent disease.
Oct 10, 2020 by Jason HawthorneNext Coronavirus Market Correction: Where to Invest $5,000When you have an opportunity to buy the best stocks on the cheap, don't outsmart yourself.
Oct 10, 2020 by Jason HawthorneCould Moderna Be a Millionaire-Maker Stock?As this biotech's coronavirus vaccine candidate speeds toward approval, it's become clear that its revolutionary development method could transform vaccines forever.
Oct 4, 2020 by Jason HawthorneMove Over, Teladoc: Are Google and Apple the Future of Telehealth?Telehealth companies have been in the headlines because of recent deals, but the future of healthcare is shaping up to be a familiar brawl between Silicon Valley titans.
Oct 3, 2020 by Jason HawthorneIs Big Tech Putting Teladoc's Future in Jeopardy?The company is using acquisitions to build a lead in virtual healthcare, but impressive competitors are laying the groundwork for future dominance.
Sep 29, 2020 by Jason HawthorneDid This Tiny Company Just Signal the All-Clear for the Healthcare Industry?A small provider of medical supplies and logistics just raised its forecast, sending its stock up more than 50%, and the healthcare industry is eyeing a recovery.
Sep 29, 2020 by Jason HawthorneHas Guardant Health Lived Up to the Hype?This company's diagnostic blood tests made it a hot IPO two years ago, but competitors are catching up, and COVID-19 could derail its critical study.
Sep 24, 2020 by Jason HawthorneFor Investors, Is Owning Johnson & Johnson Stock a Vice or a Virtue?Despite constant legal fights, this dividend aristocrat is one of the most admired companies in America -- for now.
Sep 18, 2020 by Jason HawthorneBetting Against IDEXX Labs Because of Coronavirus? You May Be Barking Up the Wrong TreeThis veterinary services-focused company has characteristics that investors love during recessions, but some metrics that may make you turtle up.
Sep 18, 2020 by Jason HawthorneFor Investors in Danaher Stock, Breaking Up Should Be Hard to DoThis transformative company is wheeling and dealing to deliver a more profitable, predictable future for shareholders.
Sep 17, 2020 by Jason HawthorneDoes This Country Offer a Crystal Ball for Intuitive Surgical's Investors?Better known for its K-pop and stylish Gangnam district, South Korea offers a glimpse at the future for investors in the maker of the da Vinci system.
Sep 16, 2020 by Jason HawthorneIs This Company the Tesla of Gene Sequencing?In a growing industry, a company with a head start can produce outsized returns for shareholders.
Sep 15, 2020 by Jason HawthorneWhat's Fueling Growth at Thermo Fisher Scientific?Corporate balance sheets are littered with failed acquisitions, but one company's experiment in buying up smaller competitors is producing great results.
Sep 15, 2020 by Jason HawthorneExcited About AstraZeneca's Coronavirus Vaccine, Are Investors Immune to the Bigger Picture?Turn off the news to find out what will drive returns.
Sep 12, 2020 by Jason HawthorneWhy Does This Healthcare Company Have So Many Imitators?Changes have brought rapid consolidation in the industry, but HCA Healthcare is ahead of the game -- it's been growing through acquisition for 50 years.
Sep 10, 2020 by Jason HawthorneWill Align Technology Stock Keep Investors Smiling?Straighter teeth build confidence for teenagers and adults, and this disruptive company is upending the traditional approach.
Sep 4, 2020 by Jason HawthorneWhy ResMed Investors Can Sleep Well at NightMany people consider themselves either value investors or growth investors. Here's why that mindset can blind them to some of the best opportunities.
